ArticleNeurology and therapy2026

Oral Corticosteroid and Nonsteroidal Immunosuppressant Therapy Use in Patients with Myasthenia Gravis Receiving Ravulizumab, Eculizumab, or Efgartigimod in the USA.

Francesco Saccà et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.